Computational Drug Designing has become the go-to requirement for the researchers, scientists and the pharmaceuticals who fight against the fatal disease. Allowing the research for the drug discovery, designing and the development to be done at an exponential speed as compared to the traditional drug development approaches.
Coronavirus disease 2019 or COVID-19 is an infectious disease that is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The COVID-19 outbreak has proven to become a deadly disease and has been declared a pandemic by World Health Organization.
Bioinformatics: Computational Drug Discovery and Design
Keeping the demand of the scientific community in-check and the free time most of the community has these days due to COVID-19. BioCode (in partners with BioAfri) is presenting an opportunity to learn Computational Drug Discovery and Design through an online workshop.
All the modules are carefully crafted so you learn from the basics of the Bioinformatics: Computational Drug Discovery and Design to the advanced level. Efficient demonstrations of the tools, methodologies, algorithms and software suites that are utilized within Computational Drug Designing will help you learn how to start the Computational Drug Designing projects, identify leads, do Molecular Docking, predict and analyze the ADMET properties, predict 3D structures of proteins and much more.